Synopsis: Tata Capital has approved a Rs 650 crore rights issue to infuse equity into its housing finance arm, TCHFL. The move aims to strengthen capital adequacy, support loan book expansion, and maintain regulatory buffers amid rising AUM growth. The capital raise...
Synopsis: Reliance Industries is in focus after Meta’s arm invested Rs 256.6 crore for a 30% stake in Reliance Enterprise Intelligence Limited, part of an Rs 853 crore capital infusion. The deal signals a strategic push into enterprise intelligence and digital...
Synopsis: Apple’s reported plans to launch Apple Pay in India by mid-2026 have raised concerns among fintech players like Pine Labs, Paytm, and AvenuesAI. While unlikely to disrupt UPI leaders immediately, Apple Pay could reshape the premium payments segment and...
Synopsis: Gravita India shares rose 4% after the company announced a Rs 49 crore capex to expand lead recycling capacity by 80,300 MTPA at its Mundra plant. The expansion strengthens growth visibility, export advantage, and operational scale, while improving investor...
Synopsis: Shares of Aditya Infotech and SpiceJet surged after significant stake transactions involving promoters and institutional investors. While Aditya Infotech witnessed Rs 920+ crore worth of stake sales absorbed by marquee institutions, SpiceJet saw a Rs 127...
Synopsis: Shares of the MRI manufacturer have corrected 66% from their peak amid valuation concerns despite strong revenue and margin expansion. While the company has demonstrated sharp growth and improving profitability, sustainability of performance in a...
Synopsis: Bajaj Holdings, Fino Payments Bank, 63 Moons Technologies, and MMTC reported significant contributions from other or exceptional income in Q3. In several cases, non-core income exceeded revenue from operations, while Bajaj Holdings’ profits were boosted by...
Synopsis: CLSA highlights a US$33 billion order opportunity for HAL over FY25–30, supported by strong backlog growth and long-term revenue visibility. Despite recent corrections, the brokerage maintains an ‘Outperform’ rating with 38% upside. Robust Q3 earnings and...
Synopsis: Concord Biotech shares surged 18% after hitting a 52-week low, driven largely by technical factors including oversold RSI levels and aggressive short covering. The rally was supported by optimism ahead of an investor meet, despite ongoing business challenges...
Synopsis: Bernstein remains positive on Swiggy and Eternal despite rising AI buzz, stating that strong logistics infrastructure protects incumbents from disruption. With AI seen as an incremental demand driver and targets implying 45–60% upside, the broking maintains...
